197 related articles for article (PubMed ID: 19059699)
1. An ENU-induced recessive mutation in Mpl leads to thrombocytopenia with overdominance.
Chan ER; Lavender H; Li G; Haviernik P; Bunting KD; Adams MD
Exp Hematol; 2009 Feb; 37(2):276-84. PubMed ID: 19059699
[TBL] [Abstract][Full Text] [Related]
2. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia.
Tijssen MR; di Summa F; van den Oudenrijn S; Zwaginga JJ; van der Schoot CE; Voermans C; de Haas M
Br J Haematol; 2008 Jun; 141(6):808-13. PubMed ID: 18422784
[TBL] [Abstract][Full Text] [Related]
4. Point mutation in the gene encoding p300 suppresses thrombocytopenia in Mpl-/- mice.
Kauppi M; Murphy JM; de Graaf CA; Hyland CD; Greig KT; Metcalf D; Hilton AA; Nicola NA; Kile BT; Hilton DJ; Alexander WS
Blood; 2008 Oct; 112(8):3148-53. PubMed ID: 18684867
[TBL] [Abstract][Full Text] [Related]
5. Quantitative trait loci analysis for peripheral blood parameters in a (BALB/cW × C57BL/6J-Mpl (hlb219)/J) F(2) mice.
Strzalkowska A; Unrug-Bielawska K; Bluszcz A; Sandowska-Markiewicz Z; Karaszewska J; Pysniak K; Gajewska M; Wirth-Dzieciolowska E
Exp Anim; 2011; 60(4):405-16. PubMed ID: 21791880
[TBL] [Abstract][Full Text] [Related]
6. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
7. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling.
Wang Q; Sun R; Wu L; Huang J; Wang P; Yuan H; Qiu F; Xu X; Wu D; Yu Y; Liu X; Zhang Q
Int J Biochem Cell Biol; 2013 Dec; 45(12):2852-63. PubMed ID: 24144576
[TBL] [Abstract][Full Text] [Related]
9. Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling.
Hirata S; Takayama N; Jono-Ohnishi R; Endo H; Nakamura S; Dohda T; Nishi M; Hamazaki Y; Ishii E; Kaneko S; Otsu M; Nakauchi H; Kunishima S; Eto K
J Clin Invest; 2013 Sep; 123(9):3802-14. PubMed ID: 23908116
[TBL] [Abstract][Full Text] [Related]
10. The thrombopoietin receptor P106L mutation functionally separates receptor signaling activity from thrombopoietin homeostasis.
Stockklausner C; Klotter AC; Dickemann N; Kuhlee IN; Duffert CM; Kerber C; Gehring NH; Kulozik AE
Blood; 2015 Feb; 125(7):1159-69. PubMed ID: 25538044
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
[TBL] [Abstract][Full Text] [Related]
12. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC
Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624
[TBL] [Abstract][Full Text] [Related]
13. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.
Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F
Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120
[TBL] [Abstract][Full Text] [Related]
14. Signals emanating from the membrane proximal region of the thrombopoietin receptor (mpl) support hematopoietic stem cell self-renewal.
Tong W; Ibarra YM; Lodish HF
Exp Hematol; 2007 Sep; 35(9):1447-55. PubMed ID: 17637498
[TBL] [Abstract][Full Text] [Related]
15. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
Heller PG; Glembotsky AC; Gandhi MJ; Cummings CL; Pirola CJ; Marta RF; Kornblihtt LI; Drachman JG; Molinas FC
Blood; 2005 Jun; 105(12):4664-70. PubMed ID: 15741216
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia.
Lambert MP; Jiang J; Batra V; Wu C; Tong W
Am J Hematol; 2012 May; 87(5):532-4. PubMed ID: 22389068
[TBL] [Abstract][Full Text] [Related]
17. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.
Alexander WS; Roberts AW; Nicola NA; Li R; Metcalf D
Blood; 1996 Mar; 87(6):2162-70. PubMed ID: 8630375
[TBL] [Abstract][Full Text] [Related]
18. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.
Ballmaier M; Germeshausen M; Schulze H; Cherkaoui K; Lang S; Gaudig A; Krukemeier S; Eilers M; Strauss G; Welte K
Blood; 2001 Jan; 97(1):139-46. PubMed ID: 11133753
[TBL] [Abstract][Full Text] [Related]
19. A structure-function analysis of serine/threonine phosphorylation of the thrombopoietin receptor, c-Mpl.
Miyakawa Y; Drachman JG; Gallis B; Kaushansky A; Kaushansky K
J Biol Chem; 2000 Oct; 275(41):32214-9. PubMed ID: 10918061
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia.
Varghese LN; Zhang JG; Young SN; Willson TA; Alexander WS; Nicola NA; Babon JJ; Murphy JM
Growth Factors; 2014 Feb; 32(1):18-26. PubMed ID: 24438083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
